Essentials of European Medical Device Regulatory Affairs - October 2019

Conformity Assessment Procedures - Options

Custom made devices: • Annex XIII • Class III: + QMS (via Annex IX or Annex XI Part A)

89

Conduct Risk Assessment

ISO 14971 Harmonised standard

•

• Risks need to be eliminated or reduced risk as far as practicable • Any remaining residual risk must be outweighed by the benefits associated with the device – risk benefit analysis. • Risk Assessment required throughout the product life cycle -Pre market AND post market. • EU specific requirements/deviations

90